3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Melanoma
69
Leukemia, Myeloid, Acute
32
Carcinoma, Renal Cell
27
Neoplasm Metastasis
17
Breast Neoplasms
16
Leukemia
15
Neuroblastoma
14
Kidney Neoplasms
14
Lymphoma, Non-Hodgkin
12
Ovarian Neoplasms
11
Carcinoma, Non-Small-Cell Lung
11
Myelodysplastic Syndromes
10
Recurrence
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Neoplasms
8
Leukemia, Lymphocytic, Chronic, B-Cell
8
Lymphoma
7
Congenital Abnormalities
7
Colorectal Neoplasms
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Skin Neoplasms
5
Multiple Myeloma
5
Lymphoma, Mantle-Cell
5
Lymphoma, Follicular
5
Head and Neck Neoplasms
5
Fallopian Tube Neoplasms
5
Carcinoma, Hepatocellular
5
Rectal Neoplasms
4
Mesothelioma, Malignant
4
Lung Neoplasms
4
Interventions
Sorafenib
42
Bevacizumab
26
Oxaliplatin
21
Radiosurgery
19
Gemcitabine
17
Fluorouracil
15
Hepatectomy
13
lenvatinib
12
Radiofrequency Ablation
11
Nivolumab
11
Cisplatin
11
Radiotherapy
10
Doxorubicin
10
Capecitabine
10
durvalumab
9
Leucovorin
9
Blood Specimen Collection
9
atezolizumab
8
Liver Transplantation
8
Everolimus
7
Electroporation
7
pembrolizumab
6
camrelizumab
6
Sunitinib
6
Immunohistochemistry
6
Cryosurgery
6
Carboplatin
6
tremelimumab
5
sintilimab
5
apatinib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Liver Neoplasms
×
Interleukin-2
×
Clear all
NCT07410494
2026-02-18
SELECT-CAR-NK
Essen Biotech
Phase 1/2
Recruiting
85 enrolled